Prokidney (PROK) Equity Ratio (2021 - 2026)

Prokidney (PROK) reported Equity Ratio of 3.5 for Q1 2026, down 42.19% year-over-year from 6.05 in Q1 2025, and down 16.04% quarter-over-quarter from 3.01 in Q4 2025.

Prokidney (PROK) Equity Ratio (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Equity Ratio data on file, last reported at 3.5 in Q1 2026.

  • Equity Ratio for Q1 2026 came in at 3.5, down 42.19% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.5 (down 42.19% YoY), and the FY2025 annual result was 3.01, down 33.58% from the prior year.
  • Equity Ratio declined to 3.5 in Q1 2026 per PROK's latest filing, from 3.01 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.08 in Q1 2022 and troughed at 3.5 in Q1 2026.
  • A 5-year average of 2.28 and a median of 2.46 in 2025 frame the typical range for Equity Ratio.
  • The sharpest annual moves came in 2023 and 2024: Equity Ratio sank 10585.1% in 2023, then climbed 28.66% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 2.12 in 2022, then declined by 23.93% to 2.62 in 2023, then climbed by 14.02% to 2.26 in 2024, then sank by 33.58% to 3.01 in 2025, then declined by 16.04% to 3.5 in 2026.
  • Business Quant data shows PROK's Equity Ratio at 3.5 in Q1 2026, 3.01 in Q4 2025, and 2.87 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 Prokidney 259.01 Mn 1.55 Bn - -3.50

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.50
Dec 31, 2025 -3.01
Sep 30, 2025 -2.87
Jun 30, 2025 -2.69
Mar 31, 2025 -2.46
Dec 31, 2024 -2.26
Sep 30, 2024 -2.06
Jun 30, 2024 -1.95
Mar 31, 2024 -2.83
Dec 31, 2023 -2.62
Sep 30, 2023 -2.42
Jun 30, 2023 -2.73
Mar 31, 2023 -3.23
Dec 31, 2022 -2.12
Sep 30, 2022 -2.06
Jun 30, 2022 0.03
Mar 31, 2022 0.08
Dec 31, 2021 0.67
Sep 30, 2021 0.04
Jun 30, 2021 25.50